Frequencies for first 10,000 rows of rx2v2c1 variable in nhamcsopd2006 dataset : for rx2, level 2 of multum drug | category #1 | Freq. Percent Cum. ----------------------------------------+----------------------------------- Anti-infectives: amebicides | 7 0.07 0.07 Anti-infectives: antifungals | 14 0.14 0.21 Anti-infectives: antituberculosis agent | 3 0.03 0.24 Anti-infectives: antiviral agents | 57 0.57 0.81 Anti-infectives: carbapenems | 1 0.01 0.82 Anti-infectives: cephalosporins | 32 0.32 1.14 Anti-infectives: macrolide derivatives | 22 0.22 1.36 Anti-infectives: miscellaneous antibiot | 37 0.37 1.73 Anti-infectives: penicillins | 37 0.37 2.10 Anti-infectives: quinolones | 25 0.25 2.35 Anti-infectives: sulfanomides | 1 0.01 2.36 Anti-infectives: tetracyclines | 7 0.07 2.43 Anti-infectives: urinary anti-infective | 9 0.09 2.52 Metabolic agents: antihyperlipidemia ag | 114 1.14 3.66 Antineoplastics: alkylating agents | 6 0.06 3.72 Antineoplastics: antibiotics/antineopla | 1 0.01 3.73 Antineoplastics: antimetabolites | 14 0.14 3.87 Antineoplastics: hormones/antineoplasti | 24 0.24 4.11 Antineoplastics: miscellaneous antineop | 5 0.05 4.16 Antineoplastics: mitotic inhibitors | 8 0.08 4.24 Immunological agents: bacterial vaccine | 42 0.42 4.66 Biologicals: colony stimulating factors | 4 0.04 4.70 Immunological agents: immune globulins | 2 0.02 4.72 Biologicals: recombinant human erythrop | 3 0.03 4.75 Immunological agents: toxoids | 20 0.20 4.95 Immunological agents: viral vaccines | 56 0.56 5.51 Immunological agents: miscellaneous bio | 2 0.02 5.53 Cardiovascular agents: angiotensin conv | 101 1.01 6.54 Cardiovascular agents: antiadrenergic a | 17 0.17 6.71 Cardiovascular agents: antiadrenergic a | 10 0.10 6.81 Cardiovascular agents: antianginal agen | 5 0.05 6.86 Cardiovascular agents: antiarrhythmic a | 59 0.59 7.45 Cardiovascular agents: beta-adrenergic | 94 0.94 8.39 Cardiovascular agents: calcium channel | 59 0.59 8.98 Cardiovascular agents: diuretics | 91 0.91 9.89 Cardiovascular agents: intropic agents | 14 0.14 10.03 Cardiovascular agents: miscellaneous ca | 1 0.01 10.04 Cardiovascular agents: vasodilators | 2 0.02 10.06 Cardiovascular agents: vasopressors | 11 0.11 10.17 Cardiovascular agents: antihypertensive | 42 0.42 10.59 Cardiovascular agents: angiotensin II i | 22 0.22 10.81 CNS: Analgesics | 517 5.17 15.98 CNS: Anticonvulsants | 130 1.30 17.28 CNS: Antiemetic/antivertigo agents: 5HT | 22 0.22 17.50 CNS: Anti-Parkinson agents | 18 0.18 17.68 CNS: Anxiolytics, sedatives, and hypnot | 251 2.51 20.19 CNS: CNS stimulants | 39 0.39 20.58 CNS: Muscle relaxants | 73 0.73 21.31 CNS: Miscellaneous CNS agents | 1 0.01 21.32 Coagulation modifiers: anticoagulants | 33 0.33 21.65 Coagulation modifiers: antiplatelet age | 21 0.21 21.86 Coagulation modifiers: misc coagulation | 1 0.01 21.87 Gastrointestinal agents: antacids | 9 0.09 21.96 Gastrointestinal agents: antidiarrheals | 6 0.06 22.02 Gastrointestinal agents: digestive enzy | 3 0.03 22.05 Gastrointestinal agents: gallstone solu | 2 0.02 22.07 Gastrointestinal agents: GI stimulants | 59 0.59 22.66 Gastrointestinal agents: H2 antagonists | 58 0.58 23.24 Gastrointestinal agents: laxatives | 41 0.41 23.65 Gastrointestinal agents: miscellaneous | 4 0.04 23.69 Hormones: adrenal cortical steroids | 56 0.56 24.25 Metabolic agents: antidiabetic agents | 149 1.49 25.74 Hormones: miscellaneous hormones | 2 0.02 25.76 Hormones: sex hormones | 60 0.60 26.36 Hormones: thyroid drugs | 38 0.38 26.74 Immunological agents: immunosuppressive | 22 0.22 26.96 Miscellaneous agents: antidotes | 2 0.02 26.98 Miscellaneous agents: chelating agents | 2 0.02 27.00 Miscellaneous agents: local injectable | 26 0.26 27.26 Miscellaneous agents: miscellaneous unc | 72 0.72 27.98 Radiologic agents: radiocontrast agents | 2 0.02 28.00 Miscellaneous agents: genitourinary tra | 23 0.23 28.23 Nutritional products: iron products | 51 0.51 28.74 Nutritional products: minerals and elec | 54 0.54 29.28 Nutritional products: oral nutritional | 3 0.03 29.31 Nutritional products: vitamins | 42 0.42 29.73 Nutritional products: vitamin and miner | 51 0.51 30.24 Respiratory agents: antihistamines | 82 0.82 31.06 Respiratory agents: antitussives | 5 0.05 31.11 Respiratory agents: bronchodilators | 186 1.86 32.97 Respiratory agents: decongestants | 13 0.13 33.10 Respiratory agents: expectorants | 15 0.15 33.25 Respiratory agents: miscellaneous respi | 2 0.02 33.27 Respiratory agents: respiratory inhalan | 23 0.23 33.50 Respiratory agents: antiasthmatic combi | 1 0.01 33.51 Respiratory agents: upper respiratory c | 70 0.70 34.21 Topical agents: antiseptics and germici | 16 0.16 34.37 Topical agents: dermatological agents | 106 1.06 35.43 Topical agents: ophthalmic preparations | 41 0.41 35.84 Topical agents: otic preparations | 8 0.08 35.92 Topical agents: sterile irrigating solu | 1 0.01 35.93 Topical agents: vaginal preprations | 11 0.11 36.04 Miscellaneous agents: antirheumatics | 13 0.13 36.17 Metabolic agents: antigout agents | 6 0.06 36.23 Hormones: biphosphonates | 18 0.18 36.41 Alternative medicines: nutraceutical pr | 11 0.11 36.52 Alternative medicines: herbal products | 9 0.09 36.61 Anti-infectives: lincomycin derivatives | 7 0.07 36.68 Respiratory agents: leukotriene modifie | 39 0.39 37.07 Topical agents: nasal preparations | 67 0.67 37.74 Psychotherapeutic agents: antidepressan | 284 2.84 40.58 Psychotherapeutic agents: antipsychotic | 96 0.96 41.54 Immunological agents: interferons | 3 0.03 41.57 Immunological agents: monoclonal antibo | 1 0.01 41.58 Gastrointestinal agents: proton pump in | 76 0.76 42.34 Respiratory agents: lung surfactants | 1 0.01 42.35 Gastrointestinal agents: 5-aminosalicyl | 2 0.02 42.37 CNS: Cholinesterase inhibitors | 2 0.02 42.39 Miscellaneous agents: smoking cessation | 4 0.04 42.43 Antineoplastics: antineoplastic monocon | 6 0.06 42.49 Gastrointestinal agents: functional bow | 11 0.11 42.60 Could not be determined | 62 0.62 43.22 . | 5,678 56.78 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 28 Mar 2016